dihydroergotamine has been researched along with phenylephrine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (92.31) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Heiss, F; Müller, V; Singh, M | 1 |
| Clasen, J; Garbe, WE | 1 |
| Kaden, F; Mäurer, W; Schömig, A; Spohr, U | 1 |
| Berlin, E; Gjöres, JE; Thulesius, O | 1 |
| Emmelin, N; Garrett, JR; Gjörstrup, P | 1 |
| Garrett, JR; Klinger, AH; Parsons, PA | 1 |
| Emmelin, N; Gjörstrup, P | 1 |
| Dick, P; Schäppi, R | 1 |
| Bühling, M; Cruz, A; Seibel, K | 1 |
| Grenié, B; Roquebert, J | 1 |
| Barthel, W; Glusa, E; Koth, W | 1 |
| Christensen, NJ; Hilsted, J | 1 |
| Arndt, JO; Inoue, H; Inoue, K | 1 |
| Schardt, F | 1 |
| Bracharz, H; Polzien, P | 2 |
| Gemeinhardt, S; Polzien, P; Schardt, F | 1 |
| Thesleff, P | 1 |
| Mishra, BR; Schardt, F | 1 |
| Rieckert, H | 1 |
| Dengler, HJ; Hengstmann, JH; Hengstmann, R; Schwonzen, S | 1 |
| Constantinescu, M; de Brito Paiva, E; Treuer, E | 1 |
| Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
1 review(s) available for dihydroergotamine and phenylephrine
| Article | Year |
|---|---|
Treatment of orthostatic hypotension.
Topics: Autonomic Nervous System Diseases; Cardiac Pacing, Artificial; Combined Modality Therapy; Diabetic Neuropathies; Dihydroergotamine; Fludrocortisone; Head; Humans; Hypotension, Orthostatic; Phenylephrine; Pindolol; Plasma Volume; Posture | 1985 |
13 trial(s) available for dihydroergotamine and phenylephrine
| Article | Year |
|---|---|
[Comparative studies on the protective effect of etilefrin and dihydroergotamine in circulatory instability after blood donation].
Topics: Adolescent; Adult; Blood Donors; Dihydroergotamine; Etilefrine; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Phenylephrine; Shock | 1978 |
[Controlled comparison of dihydroergotamine and etilofrin in orthostatic syndrome].
Topics: Adolescent; Adult; Dihydroergotamine; Etilefrine; Humans; Hypotension, Orthostatic; Male; Phenylephrine | 1978 |
[The effect of etilefrine and dihydroergotamine on sympathetic nervous system activity when standing up (author's transl)].
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Dihydroergotamine; Dopamine; Epinephrine; Etilefrine; Heart Rate; Humans; Hypotension, Orthostatic; Norepinephrine; Phenylephrine; Placebos; Posture; Sympathetic Nervous System | 1978 |
[Comparison of the effects of etilefrin and dihydroergotamine in management of the orthostatic syndrome].
Topics: Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Etilefrine; Humans; Hypotension, Orthostatic; Phenylephrine | 1979 |
[Regarding hypotension as a result of psychotropic medicaments: comparative study of two medical correctors (author's transl)].
Topics: Clinical Trials as Topic; Dihydroergotamine; Ergotamines; Humans; Hypotension; Phenylephrine; Placebos; Psychotropic Drugs | 1975 |
[Double blind study of migraine therapy with etilefrine pivalate].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Etilefrine; Female; Humans; Male; Middle Aged; Migraine Disorders; Phenylephrine; Random Allocation; Time Factors | 1985 |
[What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
Topics: Adolescent; Adult; Aged; Dihydroergotamine; Etilefrine; Humans; Hypotension, Orthostatic; Middle Aged; Phenylephrine; Placebos | 1981 |
[Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
Topics: Adult; Blood Pressure; Dihydroergotamine; Double-Blind Method; Drug Combinations; Etilefrine; Female; Heart Rate; Humans; Hypotension, Orthostatic; Male; Middle Aged; Phenylephrine; Placebos | 1980 |
[Treatment of hypotensive circulatory dysregulation with a combination of dihydroergotamine and etilefrine (author's transl)].
Topics: Adolescent; Adult; Aged; Dihydroergotamine; Drug Combinations; Etilefrine; Heart Rate; Humans; Hypotension, Orthostatic; Middle Aged; Phenylephrine; Posture | 1981 |
[Abnormalities of hypotonic orthostatic regulation: cardiovascular effects of dihydroergotamine, etilefrine and their combination (author's transl)].
Topics: Adolescent; Adult; Blood Pressure; Dihydroergotamine; Double-Blind Method; Drug Combinations; Etilefrine; Female; Heart Rate; Humans; Hypotension, Orthostatic; Male; Middle Aged; Phenylephrine; Placebos; Pulse; Time Factors | 1981 |
[Dihydergot plus - 12-hour action in orthostatic disturbance and hypotension].
Topics: Adult; Blood Pressure; Dihydroergotamine; Double-Blind Method; Drug Combinations; Etilefrine; Female; Humans; Hypotension, Orthostatic; Male; Phenylephrine; Random Allocation | 1982 |
[Therapeutic aspects of orthostatic dysfunction].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dihydroergotamine; Drug Combinations; Etilefrine; Humans; Hypotension, Orthostatic; Phenylephrine | 1982 |
[Orthostatic hypotension in the aged subject].
Topics: Age Factors; Aged; Clinical Trials as Topic; Dihydroergotamine; Etilefrine; Humans; Hypotension, Orthostatic; Phenylephrine; Random Allocation | 1983 |
12 other study(ies) available for dihydroergotamine and phenylephrine
| Article | Year |
|---|---|
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction | 1984 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
Topics: Dihydroergotamine; Ethanolamines; Etilefrine; Humans; In Vitro Techniques; Midodrine; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vasoconstrictor Agents; Veins | 1979 |
Supporting effects of myoepithelial cells in submandibular glands of dogs when acting against increased intraluminal pressure.
Topics: Animals; Dihydroergotamine; Dogs; Muscle Contraction; Muscle, Smooth; Phenylephrine; Pressure; Secretory Rate; Submandibular Gland; Sympathetic Nervous System | 1977 |
Adrenergic influences on the permeability of rabbit submandibular salivary glands to blood-borne horseradish peroxidase.
Topics: Animals; Blood; Dihydroergotamine; Epinephrine; Histocytochemistry; Horseradish Peroxidase; Isoproterenol; Microscopy, Electron; Perfusion; Peroxidases; Phenylephrine; Propranolol; Rabbits; Submandibular Gland | 1977 |
Secretory responses to sympathetic stimulation of the cat's salivary glands in a state of resting secretion.
Topics: Animals; Cats; Dihydroergotamine; Electric Stimulation; Epinephrine; Isoproterenol; Parotid Gland; Phenylephrine; Pilocarpine; Secretory Rate; Submandibular Gland; Sympathetic Nervous System | 1975 |
Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Decerebrate State; Dihydroergotamine; Electric Stimulation; Ergotamine; Hemodynamics; Male; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1986 |
Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ.
Topics: Adult; Compliance; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Interactions; Etilefrine; Femoral Artery; Femoral Vein; Humans; In Vitro Techniques; Leg; Male; Middle Aged; Norepinephrine; Phenylephrine; Skin; Vasoconstriction | 1987 |
[Interaction of dihydroergotamine and etilefrine-hydrochloride at capacitance vessels of the calf in man (author's transl)].
Topics: Adult; Dihydroergotamine; Drug Interactions; Etilefrine; Humans; Leg; Male; Phenylephrine; Regional Blood Flow | 1980 |
Secretory potentials in the submaxillary gland of the cat.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cats; Dihydroergotamine; Electric Stimulation; Evoked Potentials; Female; Male; Membrane Potentials; Parasympathetic Nervous System; Phentolamine; Phenylephrine; Submandibular Gland; Sympathetic Nervous System | 1981 |
Dihydroergotamine increases the bioavailability of orally administered etilefrine.
Topics: Administration, Oral; Adult; Biological Availability; Blood Proteins; Delayed-Action Preparations; Dihydroergotamine; Etilefrine; Female; Humans; Injections, Intravenous; Male; Phenylephrine; Protein Binding | 1982 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |